发明名称 NEW CURATIVE USE OF SMR1-PEPTIDE
摘要 PROBLEM TO BE SOLVED: To provide a method of using a medicament modulating the interaction between an endogenous SMR1-protein or -peptide and a membrane metallopeptidase, for the purpose of preparing a curative composition for preventing or treating diseases wherein modulation of the activity of the membrane metallopeptidase is sought. SOLUTION: Uses of an SMR1-peptide of formula (1): X1QHX2X3X4 are provided. In formula (1), X1 is H, or an amino acid chain selected from X1=R or G, X1=RR, X1=PRR, X1=GPRR, X1=RGPRR and X1=VRGPRR; X2 is N, G or D; X3 is P or L; and X4 is R or T. The SMR1-peptide acts by inhibiting NEP or by inhibiting enkephalin degradation, etc. COPYRIGHT: (C)2009,JPO&INPIT
申请公布号 JP2009007352(A) 申请公布日期 2009.01.15
申请号 JP20080149611 申请日期 2008.06.06
申请人 INST PASTEUR;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) 发明人 ROUGEOT CATHERINE;ROUGEON FRANCOIS
分类号 A61K38/00;G01N33/50;A61K38/22;A61K45/00;A61P1/04;A61P1/12;A61P7/10;A61P9/10;A61P9/12;A61P13/02;A61P19/02;A61P25/00;A61P25/04;A61P25/14;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P27/00;A61P29/00;A61P31/00;A61P31/04;A61P31/12;A61P35/00;A61P37/02;A61P43/00;C07K14/575;C12Q1/00;C12Q1/02;C12Q1/37;G01N33/15;G01N33/566 主分类号 A61K38/00
代理机构 代理人
主权项
地址